دورية أكاديمية

Design, synthesis and molecular modeling study of certain 4-Methylbenzenesulfonamides with CDK2 inhibitory activity as anticancer and radio-sensitizing agents.

التفاصيل البيبلوغرافية
العنوان: Design, synthesis and molecular modeling study of certain 4-Methylbenzenesulfonamides with CDK2 inhibitory activity as anticancer and radio-sensitizing agents.
المؤلفون: Ghorab MM; Department of Drug Radiation Research, National Centre for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), PO box 29, Nasr City, Cairo, Egypt. Electronic address: mmsghorab@yahoo.com., Ragab FA; Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt., Heiba HI; Department of Drug Radiation Research, National Centre for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), PO box 29, Nasr City, Cairo, Egypt., Elsayed MSA; Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, and the Purdue Center for Cancer Research, Purdue University, West Lafayette, IN 47907, United States., Ghorab WM; Department of Drug Radiation Research, National Centre for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), PO box 29, Nasr City, Cairo, Egypt.
المصدر: Bioorganic chemistry [Bioorg Chem] 2018 Oct; Vol. 80, pp. 276-287. Date of Electronic Publication: 2018 Jun 05.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2120 (Electronic) Linking ISSN: 00452068 NLM ISO Abbreviation: Bioorg Chem Subsets: MEDLINE
أسماء مطبوعة: Publication: Amsterdam : Elsevier
Original Publication: New York, London, Academic Press.
مواضيع طبية MeSH: Drug Design*, Antineoplastic Agents/*chemical synthesis , Cyclin-Dependent Kinase 2/*metabolism , Protein Kinase Inhibitors/*chemical synthesis , Sulfonamides/*chemistry , Toluene/*analogs & derivatives, Antineoplastic Agents/metabolism ; Antineoplastic Agents/pharmacology ; Binding Sites ; Catalytic Domain ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cyclin-Dependent Kinase 2/antagonists & inhibitors ; Drug Screening Assays, Antitumor ; Gamma Rays ; Humans ; Molecular Docking Simulation ; Protein Kinase Inhibitors/metabolism ; Protein Kinase Inhibitors/pharmacology ; Structure-Activity Relationship ; Sulfonamides/metabolism ; Sulfonamides/pharmacology ; Toluene/chemistry ; Toluene/metabolism ; Toluene/pharmacology
مستخلص: Two series of 2-aminopyridine derivatives 6-17 and tyrphostin AG17 analogs 18-22 bearing 4-methylbenzenesulfonamide moiety were designed and synthesized as anticancer compounds. The synthesized compounds were biologically evaluated for their cytotoxic activity against human breast cancer cell line MCF-7. From 2-aminopyridine and tyrphostin AG17 series, compounds 14, 16 and 20 showed the best activities with IC 50 values of 20.4, 18.3 and 26.3 µM, respectively compared to E7070 IC 50 36.3 µM. Further biological evaluation of 14, 16 and 20 against cyclin dependent kinase-2 (CDK2) revealed good inhibitory activity with IC 50 of 2.53, 1.79 and 2.92 µM, respectively compared to roscovitine IC 50 0.43 µM. Additionally, capability of γ-radiation to augment the cytotoxic activity of 14, 16 and 20 was studied and showed a dramatic increase in the cell killing effect at lower concentrations after irradiation. Docking was used to investigate the possible binding modes of compounds 14, 16 and 20 inside the active site of CDK2 enzyme.
(Copyright © 2018 Elsevier Inc. All rights reserved.)
فهرسة مساهمة: Keywords: 2-Aminopyridine; 4-methylbenzenesulfonamide; CDK2; Cytotoxic; Tyrphostin AG17 analogs; γ-radiation
المشرفين على المادة: 0 (Antineoplastic Agents)
0 (Protein Kinase Inhibitors)
0 (Sulfonamides)
3FPU23BG52 (Toluene)
EC 2.7.11.22 (CDK2 protein, human)
EC 2.7.11.22 (Cyclin-Dependent Kinase 2)
I8266RI90M (4-toluenesulfonamide)
تواريخ الأحداث: Date Created: 20180704 Date Completed: 20190422 Latest Revision: 20190422
رمز التحديث: 20240628
DOI: 10.1016/j.bioorg.2018.06.010
PMID: 29966874
قاعدة البيانات: MEDLINE
الوصف
تدمد:1090-2120
DOI:10.1016/j.bioorg.2018.06.010